Universität zu Köln

Journal Article

Brunn, A., Utermoehlen, O., Mihelcic, M., Sanchez-Ruiz, M., Carstov, M., Blau, T., Ustinova, I., Penfold, M., Montesinos-Rongen, M. and Deckert, M. (2013). Differential effects of CXCR4-CXCL12-and CXCR7-CXCL12-mediated immune reactions on murine P0(106-125)-induced experimental autoimmune neuritis. Neuropathol. Appl. Neurobiol., 39 (7). S. 772 - 788. HOBOKEN: WILEY. ISSN 1365-2990

Ceccon, G. S., Werner, J., Ruge, M., I, Goldbrunner, R., Celik, E., Baues, C., Deckert, M., Brunn, A., Buttner, R., Golla, H., Nogova, L., Schlamann, M., Kabbasch, C., Ruess, D., Hampl, J., Wollring, M., Bauer, E. K., Tscherpel, C., Fink, G. R., Langen, K. and Galldiks, N. (2022). Impact of FET PET on multidisciplinary neurooncological tumor board decisions in patients with brain tumors. Neuro-Oncology, 24. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Deckert, M., Engert, A., Brueck, W., Ferreri, A. J. M., Finke, J., Illerhaus, G., Klapper, W., Korfel, A., Kueppers, R., Maarouf, M., Montesinos-Rongen, M., Paulus, W., Schlegel, U., Lassmann, H., Wiestler, O. D., Siebert, R. and DeAngelis, L. M. (2011). Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. Leukemia, 25 (12). S. 1797 - 1808. LONDON: NATURE PUBLISHING GROUP. ISSN 0887-6924

Deng, M. Y., Sill, M., Sturm, D., Stichel, D., Witt, H., Ecker, J., Wittmann, A., Schittenhelm, J., Ebinger, M., Schuhmann, M. U., Figarella-Branger, D., Aronica, E., Staszewski, O., Preusser, M., Haberler, C., Lauten, M., Schueller, U., Hartmann, C., Snuderl, M., Dunham, C., Jabado, N., Wesseling, P. ORCID: 0000-0001-5453-5201, Deckert, M., Keyvani, K., Gottardo, N., Giangaspero, F., von Hoff, K., Ellison, D. W., Pietsch, T., Herold-Mende, C., Milde, T., Witt, O., Kool, M., Korshunov, A., Wick, W., von Deimling, A., Pfister, S. M., Jones, D. T. W. and Sahm, F. (2020). Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC) - a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14. Neuropathol. Appl. Neurobiol., 46 (5). S. 422 - 431. HOBOKEN: WILEY. ISSN 1365-2990

Ferreri, A. J. M., Cwynarski, K., Pulczynski, E., Fox, C. P., Schorb, E., La Rosee, P., Binder, M., Fabbri, A., Torri, V., Minacapelli, E., Falautano, M., Ilariucci, F., Ambrosetti, A., Roth, A., Hemmaway, C., Johnson, P., Linton, K. M., Pukrop, T., Gorlov, J. S., Balzarotti, M., Hess, G., Keller, U., Stilgenbauer, S., Panse, J., Tucci, A., Orsucci, L., Pisani, F., Levis, A., Krause, S., Schmoll, H. J., Hertenstein, B., Zaccaria, A., Guarini, A., Atta, J., Bassan, R., Cervetti, J., Elter, T., Enggaard, L., Haenel, M., Kneba, M., Liberati, M., Martelli, M., Martens, U., Morra, E., Pinto, A., Zaja, F., Ponzoni, M., Deckert, M., Politi, L. S., Finke, J., Reni, M., Cavalli, F., Zucca, E. and Illerhaus, G. (2017). Autologous stem cell transplantation (ASCT) or whole-brain radiotherapy (WBRT) as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with newly diagnosed primary cns lymphoma (PCNSL): results of the IELSG32 randomized Phase II Trial. Bone Marrow Transplant., 52. S. S96 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Filipova, D., Walter, A., Gaspar, J., Brunn, A., Deckert, M., Sachinidis, A., Pfitzer, G. and Papadopoulos, S. (2017). Transcriptomic changes during skeletal muscle development in the presence and absence of the type 1 ryanodine receptor (RYR1). Acta Physiol., 219. S. 38 - 39. HOBOKEN: WILEY. ISSN 1748-1716

Filipova, D., Walter, A. M., Gasper, J. A., Brunn, A., Deckert, M., Sachinidis, A., Pfitzer, G. and Papadopoulos, S. (2016). Profound changes in the gene expression of skeletal muscle lacking the type 1 ryanodine receptor (RYR1). Acta Physiol., 216. HOBOKEN: WILEY-BLACKWELL. ISSN 1748-1716

Fritsch, K., Kasenda, B., Schorb, E., Hau, P., Bloehdorn, J., Moehle, R., Loew, S., Binder, M., Atta, J., Keller, U., Wolf, H-H, Krause, S. W., Hess, G., Naumann, R., Sasse, S., Hirt, C., Lamprecht, M., Martens, U., Morgner, A., Panse, J., Frickhofen, N., Roeth, A., Hader, C., Deckert, M., Fricker, H., Ihorst, G., Finke, J. and Illerhaus, G. (2017). High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study). Leukemia, 31 (4). S. 846 - 853. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Illerhaus, G., Cwynarski, K., Pulczynski, E., Ponzoni, M., Deckert, M., Politi, L. S., Fox, C. P., La Rose, P., Ambrosetti, A., Roeth, A., Hemmaway, A., Ilariucci, F., Linton, K. M., Soffietti, R., Pukrop, T., Binder, M., Balzarotti, M., Fabbri, A., Johnson, P., Gorlov, J. S., Cavalli, F., Finke, J., Schorb, E., Reni, M., Zucca, E. and Ferrer, A. J. M. (2015). Improved outcome with addition of thiotepa and rituximab to methotrexate and cytarabine in primary cns lymphoma: Results of the first randomization of the IELSG-32 trial. Oncol. Res. Treat., 38. S. 177 - 178. BASEL: KARGER. ISSN 2296-5262

Neugebauer, A., Herkenrath, P., Koerber, F., Simon, T., Brunn, A., Deckert, M. and Fricke, J. (2016). Strabologic and neuro-ophthamologic aspects of childhood cancer. Ophthalmologe, 113 (7). S. 557 - 568. NEW YORK: SPRINGER. ISSN 1433-0423

Vater, I., Montesinos-Rongen, M., Schlesners, M., Haakel, A., Purschke, F., Sprute, R., Mettenmeyer, N., Nazzal, I., Nagel, I., Gutwein, J., Richter, J., Buchhalter, I., Russell, R. B., Wiestler, O. D., Eils, R., Deckert, M. and Siebert, R. (2015). The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing. Leukemia, 29 (3). S. 677 - 686. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Vater, I., Montesinos-Rongen, M., Schlesners, M., Haakel, A., Purschke, F., Sprute, R., Mettenmeyer, N., Nazzal, I., Nagel, I., Gutwein, J., Richter, J., Buchhalter, I., Russell, R. B., Wiestler, O. D., Eils, R., Deckert, M. and Siebert, R. (2015). The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing. Leukemia, 29 (3). S. 677 - 686. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Werner, J., Wolf, L., Tscherpel, C., Bauer, E. K., Wollring, M., Ceccon, G., Deckert, M., Brunn, A., Pappesch, R., Goldbrunner, R., Fink, G. R. and Galldiks, N. (2022). EFFICACY AND TOLERABILITY OF REGORAFENIB IN PRETREATED PATIENTS WITH PROGRESSIVE CNS GRADE 3 OR 4 GLIOMAS. Neuro-Oncology, 24. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866